Previous close | 165.54 |
Open | 166.03 |
Bid | 0.00 x 900 |
Ask | 0.00 x 1200 |
Day's range | 163.89 - 166.34 |
52-week range | 155.72 - 186.69 |
Volume | |
Avg. volume | 7,077,178 |
Market cap | 430.37B |
Beta (5Y monthly) | 0.57 |
PE ratio (TTM) | 24.46 |
EPS (TTM) | 6.73 |
Earnings date | 18 Apr 2023 |
Forward dividend & yield | 4.52 (2.74%) |
Ex-dividend date | 17 Feb 2023 |
1y target est | 183.63 |
Out of the Dow Jones Industrial Average's 30 components, there are three amazing deals hiding in plain sight.
Companies whose businesses were buoyed or boosted by Covid product demand are facing a cliff in 2023, and will have to pivot to more traditional strategies.
NEW BRUNSWICK, N.J., February 02, 2023--Johnson & Johnson (NYSE: JNJ) will participate in the Cowen 43rd Annual HealthCare Conference on Tuesday, March 7th, at the Boston Marriott Copley Place, Boston, MA. Joseph J. Wolk, Executive Vice President and Chief Financial Officer will represent the Company in a session scheduled at 11:10 a.m. (Eastern Time).